Multifunctional PEG Carrier by Chemoenzymatic Synthesis for Drug Delivery Systems: In Memory of Professor Andrzej Dworak

• Published in: Polymers
• Main Authors: Judit E. Puskas, Gayatri Shrikhande, Eniko Krisch, Kristof Molnar
• Format: Article in Journal/Newspaper
• Language: English
• Published: MDPI AG 2022
• Subjects: enzyme catalysis; discrete poly(ethylene glycol) dPEG; polymer drug conjugate; modular assembly; doxorubicin; folic acid; Organic chemistry; QD241-441; Antarc*; Antarctica
• Online Access: https://doi.org/10.3390/polym14142900; https://doaj.org/article/00c7180bad1743649a6b474b43114d68

This paper describes the synthesis and characterization of new bivalent folate-targeted PEGylated doxorubicin (FA 2 -dPEG-DOX 2 ) made by modular chemo-enzymatic processes using Candida antarctica lipase B (CALB) as a biocatalyst. Unique features are the use of monodisperse PEG (dPEG) and the synthesis of thiol-functionalized folic acid yielding exclusive γ-conjugation of folic acid (FA) to dPEG. The polymer-based drug conjugate is built up by a series of transesterification and Michael addition reactions all catalyzed be CALB. In comparison with other methods in the literature, the modular approach with enzyme catalysis leads to selectivity, full conversion and high yield, and no transition metal catalyst residues. The intermediate product with four acrylate groups is an excellent platform for Michael-addition-type reactions for a wide variety of biologically active molecules. The chemical structures were confirmed by nuclear magnetic resonance spectroscopy (NMR). Flow cytometry analysis showed that, at 10 µM concentration, both free DOX and FA 2 -dPEG-DOX 2 were taken up by 99.9% of triple-negative breast cancer cells in 2 h. Fluorescence was detected for 5 days after injecting compound IV into mice. Preliminary results showed that intra-tumoral injection seemed to delay tumor growth more than intravenous delivery.